Internal Medicine, Endocrinology, Diabetes, & Metabolism · Katy, TX
NPI
1659508265
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
21308 Provincial Blvd
Katy, TX, 77450
Phone (281) 206-8201
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
384 services
Medicare patients, 2024
145
Average age 72
Drug cost, 2024
$916K
2,219 prescriptions
Company payments, 2025
$676
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Johanna Vivienne F Leyco-Policarpio was code 99214 (office e&m - established), 246 times for 118 patients. In total Johanna Vivienne F Leyco-Policarpio billed 384 services in 7 codes, and Medicare paid $35K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 246 | 118 | $89.91 | $22K |
| 99215 Office E&M - Established | Office | 48 | 34 | $128.88 | $6,186 |
| 95251 Test - Miscellaneous | Office | 45 | 24 | $26.32 | $1,185 |
| 99205 Office E&M - New | Office | 20 | 20 | $163.29 | $3,266 |
| 99204 Office E&M - New | Office | 13 | 13 | $97.31 | $1,265 |
By year: 2022 $48K for 1,274 services; 2023 $30K for 334 services; 2024 $35K for 384 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 110 | 74 | $10.43 | $1,147 |
| 84443 Clinical Chemistry | 97 | 64 | $16.57 | $1,608 |
| 82962 Clinical Chemistry | 97 | 57 | $3.24 | $314 |
| 84439 Clinical Chemistry | 90 | 57 | $8.90 | $801 |
| 80061 Clinical Chemistry | 76 | 54 | $13.23 | $1,006 |
| 83036 Blood Count | 75 | 52 | $9.59 | $720 |
| 36415 Venipuncture Blood Collection | 46 | 38 | $2.96 | $136 |
| 85025 Blood Count | 42 | 32 | $7.49 | $315 |
| 82306 Clinical Chemistry | 39 | 35 | $29.25 | $1,141 |
| 84100 Clinical Chemistry | 11 | 11 | $4.68 | $51.49 |
Medicare prescription drug claims, 2024
In 2024, the drug Johanna Vivienne F Leyco-Policarpio prescribed most often to Medicare patients was Levothyroxine Sodium, with 232 prescriptions and refills. In total Johanna Vivienne F Leyco-Policarpio wrote 2,219 Medicare prescriptions that cost $916K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 232 | 656 | 69 | $3,027 |
| Mounjaro Tirzepatide | 194 | 229 | 28 | $230K |
| Metformin Hcl Er Metformin Hcl | 187 | 503 | 69 | $1,680 |
| Ozempic Semaglutide | 181 | 276 | 40 | $262K |
| Jardiance Empagliflozin | 80 | 170 | 22 | $98K |
| Alendronate Sodium Generic | 63 | 154 | 22 | $440 |
| Pioglitazone Hcl Generic | 62 | 156 | 21 | $405 |
| Atorvastatin Calcium Generic | 56 | 165 | 21 | $634 |
| Rosuvastatin Calcium Generic | 54 | 159 | 17 | $708 |
| Synthroid Levothyroxine Sodium | 50 | 136 | 16 | $4,161 |
| Lisinopril Generic | 42 | 127 | 15 | $319 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 38 | 60 | Under 11 | $32K |
| Metformin Hcl Generic | 38 | 108 | 11 | $785 |
| Liothyronine Sodium Generic | 36 | 108 | 12 | $1,193 |
| Losartan Potassium Generic | 35 | 95 | 14 | $310 |
Brand drugs: 947 claims; generic drugs: 1,123 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Johanna Vivienne F Leyco-Policarpio $676 ($676 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $223.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 15 | $223 |
| Lilly USA, LLC LLY | 5 | $86.3 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $81.48 |
| Abbott Laboratories ABT | 3 | $63.49 |
| Beta Bionics, Inc. BBNX | 2 | $39.03 |
| Esperion Therapeutics, Inc. ESPR | 2 | $31.35 |
| Kyowa Kirin, Inc. 4151.T | 1 | $25.56 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $24.68 |
| Almatica Pharma LLC | 1 | $21.62 |
| Corcept Therapeutics CORT | 1 | $17.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.